Immunogenicity 12056
Sample ID
3998
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ACSL5
Transcript ID
uc009xxz.3
HLA INFO
B*18:01
TCR INFO
No TCR info found!
Full length protein sequence (659 aa)
MLFIF
1
NFLFS
6
PLPTP
11
ALICI
16
LTFGA
21
AIFLW
26
LITRP
31
QPVLP
36
LLDLN
41
NQSVG
46
IEGGA
51
RKGVS
56
QKNND
61
LTSCC
66
FSDAK
71
TMYEV
76
FQRGL
81
AVSDN
86
GPCLG
91
YRKPN
96
QPYRW
101
LSYKQ
106
VSDRA
111
EYLGS
116
CLLHK
121
GYKSS
126
PDQFV
131
GIFAQ
136
NRPEW
141
IISEL
146
ACYTY
151
SMVAV
156
PLYDT
161
LGPEA
166
IVHIV
171
NKADI
176
AMVIC
181
DTPQK
186
ALVLI
191
GNVEK
196
GFTPS
201
LKVII
206
LMDPF
211
DDDLK
216
QRGEK
221
SGIEI
226
LSLYD
231
AENLG
236
KEHFR
241
KPVPP
246
SPEDL
251
SVICF
256
TSGTT
261
GDPKG
266
AMITH
271
QNIVS
276
NAAAF
281
LKCVE
286
HAYEP
291
TPDDV
296
AISYL
301
PLAHM
306
FERIV
311
QAVVY
316
SCGAR
321
VGFFQ
326
GDIRL
331
LADDM
336
KTLKP
341
TLFPA
346
VPRLL
351
NRIYD
356
KVQNE
361
AKTPL
366
KKFLL
371
KLAVS
376
SKFKE
381
LQKGI
386
IRHDS
391
FWDKL
396
IFAKI
401
QDSLG
406
GRVRV
411
IVTGA
416
APMST
421
SVMTF
426
FRAAM
431
GCQVY
436
EAYGQ
441
TECTG
446
GCTFT
451
LPGDW
456
TSGHV
461
GVPLA
466
CNYVK
471
LEDVA
476
DMNYF
481
TVNNE
486
GEVCI
491
KGTNV
496
FKGYL
501
KDPEK
506
TQEAL
511
DSDGW
516
LHTGD
521
IGRWL
526
PNGTL
531
KIIDR
536
KKNIF
541
KLAQG
546
EYIAP
551
EKIEN
556
IYNRS
561
QPVLQ
566
IFVHG
571
ESLRS
576
SLVGV
581
VVPDT
586
DVLPS
591
FAAKL
596
GVKGS
601
FEELC
606
QNQVK
611
AIFLH
616
PEPFS
621
IENGL
626
LTPTL
631
KAKRG
636
ELSKY
641
FRTQI
646
DSLYE
651
HIQD
656
Mutation Information
DNA mutation:
None
Peptide Range:
136 ~ 160
Mut AA position:
148 (13 in Wild Type peptide)
Alignment
Wild Type:
"GIFAQNRPEWIISELACYTYSMVAV
||||||||||||.||||||||||||
Mutant:
GIFAQNRPEWIIFELACYTYSMVAV"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ACSL5
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
COS7
Assay
IFNg ELISPOT assay